Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer: A 9-year review

doi:10.4240/wjgs.v16.i3.777

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (782)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

489

Figures (1-2)

Tables (1-4)

Sum=688

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=69

Mar 27, 2024 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Mar 27, 2024; 16(3): 777-789
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.777

Table 1 Clinical demographics of patients who underwent multivisceral resection, n (%)

	Total (n = 46)	Minimally invasive (n = 34)	Open (n = 12)	P value^a
Age, yr	68.0 (44.0-85.0)	68.0 (44.0-85.0)	67.5 (45.0-85.0)	0.573
Sex, male (%)	21 (45.7)	15 (44.1)	6 (50)	0.725
BMI, kg/m²	22.5 (12.6-37.9)	22.0 (12.6-32.1)	23.3 (16.4-37.9)	0.708
ASA score, median	2.0 (1.0-3.0)	2.0 (1.0-3.0)	2.0 (1.0-3.0)	0.966
1	13 (28.3)	10 (29.4)	3 (25.0)
2	27 (58.7)	19 (55.9)	8 (66.7)
3	6 (13.0)	5 (14.7)	1 (8.3)
Co-morbidities
Hypertension	23 (50.0)	17 (50.0)	6 (50.0)	1.000
Hyperlipidemia	18 (39.1)	14 (41.2)	4 (33.3)	0.632
Diabetes mellitus	11 (23.9)	9 (26.5)	2 (16.7)	0.494
Ischemic heart disease	3 (6.5)	3 (8.8)	0 (0)	0.287
Previous abdominal surgery	7 (15.2)	5 (14.7)	2 (16.7)	0.871
Neoadjuvant chemotherapy	31 (67.4)	25 (73.5)	6 (50.0)	0.135
Neoadjuvant radiotherapy	36 (78.3)	29 (85.3)	7 (58.3)	0.052
Previous local recurrence	3 (6.5)	2 (5.9)	1 (8.3)	0.768

^aStatistical significance is expressed as P < 0.05.

All continuous variables were expressed as median (range) unless specified. All categorical variables were expressed as n (%) unless otherwise specified. ASA: American Society of Anesthesiologists; BMI: Body mass index.

Table 2 Intra-operative characteristics of patients who underwent multivisceral resection, n (%)

	Total (n = 46)	Minimally invasive (n = 34)	Open (n = 12)	P value
Surgical access				N/A
Laparoscopic	13 (28.3)	13 (38.2)	-
Robotic	21 (45.7)	21 (61.8)	-
Urgency of surgery				0.015^a
Elective	44 (95.7)	34 (100)	10 (83.3)
Emergency	2 (4.3)	0 (0)	2 (16.7)
Type of surgery				0.147
ULAR with DI	30 (65.2)	25 (73.5)	5 (41.7)
APR	11 (23.9)	6 (17.6)	5 (41.7)
Hartmann’s procedure	3 (6.5)	2 (5.9)	1 (8.3)
LAR	1 (2.2)	0 (0)	1 (8.3)
taTME	1 (2.2)	1 (2.9)	0 (0)
Extent of resection				-
En-bloc seminal vesicles	5 (10.9)	5 (14.7)	0 (0)
Posterior vaginectomy	4 (8.7)	4 (11.8)	0 (0)
Salpingo-oopherectomy	1 (2.2)	1 (2.9)	0 (0)
Bladder sparing prostatectomy	5 (10.9)	4 (11.8)	1 (8.3)
Posterior exanteration	22 (47.8)	16 (47.1)	6 (50.0)
Total pelvic exanteration	9 (19.6)	4 (11.8)	5 (41.7)
Small bowel resection	1 (2.2)	1 (2.9)	0 (0)
Sacrectomy	3 (6.5)	0 (0)	3 (25.0)
Initial stoma creation	35 (76.1)	27 (79.4)	7 (58.3)	0.153
Eventual reversal	18 (51.4)	15 (55.6)	3 (42.9)
Intra-operative ureteric injury	2 (4.3)	2 (5.9)	0 (0)	0.390
Operating time, min	562 (225-900)	566.5 (275-900)	502.5 (225-751)	0.150
Estimated blood loss, mL	500 (0-4000)	450 (0-2400)	1200 (200-4000)	0.008^a
Pathological TNM stage				0.836
Complete pathological response	1 (2.2)	1 (2.9)	0 (0)
1	1 (2.2)	1 (2.9)	0 (0)
2	20 (43.5)	15 (44.1)	5 (41.7)
3	17 (37.0)	11 (32.4)	6 (50.0)
4	7 (15.2)	6 (17.6)	1 (8.3)
R0 resection	37 (80.4)	27 (79.4)	10 (83.3)	0.768

^aP < 0.05. Values indicate statistical significance, where P < 0.05.

All continuous variables were expressed as median (range) unless specified. All categorical variables were expressed as n (%) unless otherwise specified. APR: Abdominoperineal resection; DI: Defunctioning ileostomy; N/A: Not applicable; LAR: Low anterior resection; taTME: Transanal total mesorectal excision; TNM: Tumour, Node, Metastasis; ULAR: Ultra-low anterior resection.

Table 3 Post-operative outcomes of patients who underwent multivisceral resection, n (%)

	Total (n = 46)	Minimally invasive (n = 34)	Open (n = 12)	P value
Short-term complications
Anastomotic leak	7 (15.2)	4 (11.8)	3 (25.0)	0.272
Intra-abdominal collection	10 (21.7)	4 (11.8)	6 (50.0)	0.006^a
Ileus	19 (41.3)	11 (32.4)	8 (66.7)	0.038^a
SSI	10 (21.7)	4 (11.8)	6 (50.0)	0.006^a
Pneumonia	2 (5.9)	2 (5.9)	0 (0)	0.390
Overall complications	30 (65.2)	20 (58.8)	10 (83.3)	0.125
Major morbidity	11 (23.9)	5 (14.7)	6 (50.0)	0.014^a
Length of stay, d	12.0 (3.0-62.0)	10.0 (3.0-42.0)	30.0 (6.0-62.0)	< 0.001^a
30-d readmission	11 (23.9)	8 (23.5)	3 (25.0)	0.918
30-d mortality	0 (0)	0 (0)	0 (0)	N/A
Adjuvant chemotherapy	31 (67.4)	24 (70.6)	7 (58.3)	0.436
Follow-up, months	32.2 (1.1-100.8)	29.2 (1.1-100.8)	36.2 (2.2-73.9)	0.582
Overall survival
Median, months	43.2 (41.5-N/A)	43.1 (40.4-N/A)	47.1 (14.5-N/A)	0.257
1-year	93.2 (80.3-97.8)	93.9 (77.6-98.4)	91.3 (52.4-98.7)	0.774
3-year	71.5 (54.1-83.3)	71.1 (49.8-84.6)	72.1 (35.9-90.1)	0.473
5-year	36.5 (18.2-55.0)	32.1 (11.9-54.6)	45.9 (13.6-73.8)	0.446
Recurrence-free survival
Median, months	43.2 (19.5-N/A)	43.2 (15.4-N/A)	47.1 (3.6-N/A)	0.501
1-year	77.3 (61.9-87.1)	75.4 (56.8-86.9)	82.6 (46.5-95.3)	0.800
3-year	60.8 (43.8-74.1)	56.1 (36.0-72.2)	72.9 (37.1-90.4)	0.879
5-year	37.1 (19.0-55.3)	33.7 (13.1-55.8)	17.2 (13.8-74.2)	0.371

^aP < 0.05. Values indicate statistical significance, where P < 0.05.

All continuous variables were expressed as median (range) unless specified. All categorical variables were expressed as n (%) unless otherwise specified. N/A: Not applicable; SSI: Surgical site infection.

Table 4 Subgroup analysis comparing outcomes of patients who had minimally invasive multivisceral resection, n (%)

	Robotic (n = 21)	Laparoscopic (n = 13)	P value
Intra-operative ureteric injury	1 (4.8)	1 (7.7)	0.724
Open conversion	1 (4.8)	3 (23.1)	0.107
Surgical complexity			0.004^a
Simple	9 (42.9)	12 (92.3)
Complex	12 (57.1)	1 (7.7)
Short-term complications
Anastomotic leak	1 (4.8)	3 (23.1)	0.107
Intra-abdominal collection	1 (4.8)	3 (23.1)	0.107
Ileus	6 (28.6)	5 (38.5)	0.549
SSI	1 (4.8)	3 (23.1)	0.107
Pneumonia	1 (4.8)	1 (7.7)	0.724
Overall complications	12 (57.1)	8 (61.5)	0.800
Major morbidity	3 (14.3)	2 (15.4)	0.930
Length of stay, d		11.0 (4.0-28.0)	0.807
30-d readmission	5 (23.8)	3 (23.1)	0.961
30-d mortality	0 (0)	0 (0)	N/A
Adjuvant chemotherapy	15 (71.4)	9 (69.2)	0.891
Follow-up, months	24.2 (4.8-100.8)	41.5 (1.1-76.5)	0.158
Overall survival
Median, months	43.2 (43.1-N/A)	40.4 (12.9-53.0)	0.149
1-year	95.0 (69.5-99.3)	92.0 (55.3-98.8)	0.083
3-year	83.1 (56.1-94.3)	58.6 (27.2-80.2)	0.008^a
5-year	49.9 (13.1-78.8)	21.0 (3.7-47.9)	0.175
Recurrence-free survival
Median, months	43.2 (19.5-N/A)	12.9 (2.6-53.0)	0.096
1-year	85.0 (60.4-94.9)	60.0 (29.0-81.0)	0.607
3-year	72.9 (46.2-87.8)	34.3 (10.8-59.8)	0.002^a
5-year	40.5 (9.3-70.9)	22.9 (4.3-50.1)	0.070

^aP < 0.05. Values in bold indicate statistical significance, where P < 0.05.

Citation: Chan KS, Liu B, Tan MNA, How KY, Wong KY. Feasibility and safety of minimally invasive multivisceral resection for T4b rectal cancer: A 9-year review. World J Gastrointest Surg 2024; 16(3): 777-789
URL: https://www.wjgnet.com/1948-9366/full/v16/i3/777.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.777